0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Exosome Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-6M13880
Home | Market Reports | Health| Health Foundations & Medical Research
Global Exosome Therapy Market Research Report 2023
BUY CHAPTERS

Exosome Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6M13880
Report
November 2024
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Exosome Therapy - Market Size

The global market for Exosome Therapy was estimated to be worth US$ 1897.3 million in 2023 and is forecast to a readjusted size of US$ 2764 million by 2030 with a CAGR of 6.1% during the forecast period 2024-2030

Exosome Therapy - Market

Exosome Therapy - Market

Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Exosome Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Exosome Therapy by region & country, by Type, and by Application.
The Exosome Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Therapy.
Market Segmentation

Scope of Exosome Therapy - Market Report

Report Metric Details
Report Name Exosome Therapy - Market
Forecasted market size in 2030 US$ 2764 million
CAGR 6.1%
Forecasted years 2024 - 2030
Segment by Type:
  • Direct Treatment
  • Drug Delivery Vehicle
Segment by Application
  • Hospital
  • Clinic
  • Research Institutions
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company United Therapeutics Corporation, Codiak BioSciences, EngEx™, Esperite Group, ArunA Biomedical, Evox Therapeutics, NeurExo Sciences, Tavec Pharmaceuticals, AEGLE Therapeutics, Avalon GloboCare, AlligatorBioscience, Capricor Therapeutics, Stem Cell Medicine, CellTex Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Exosome Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Exosome Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Exosome Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Exosome Therapy - Market size in 2030?

Ans: The Exosome Therapy - Market size in 2030 will be US$ 2764 million.

Who are the main players in the Exosome Therapy - Market report?

Ans: The main players in the Exosome Therapy - Market are United Therapeutics Corporation, Codiak BioSciences, EngEx™, Esperite Group, ArunA Biomedical, Evox Therapeutics, NeurExo Sciences, Tavec Pharmaceuticals, AEGLE Therapeutics, Avalon GloboCare, AlligatorBioscience, Capricor Therapeutics, Stem Cell Medicine, CellTex Therapeutics

What are the Application segmentation covered in the Exosome Therapy - Market report?

Ans: The Applications covered in the Exosome Therapy - Market report are Hospital, Clinic, Research Institutions

What are the Type segmentation covered in the Exosome Therapy - Market report?

Ans: The Types covered in the Exosome Therapy - Market report are Direct Treatment, Drug Delivery Vehicle

1 Market Overview
1.1 Exosome Therapy Product Introduction
1.2 Global Exosome Therapy Market Size Forecast
1.3 Exosome Therapy Market Trends & Drivers
1.3.1 Exosome Therapy Industry Trends
1.3.2 Exosome Therapy Market Drivers & Opportunity
1.3.3 Exosome Therapy Market Challenges
1.3.4 Exosome Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Exosome Therapy Players Revenue Ranking (2023)
2.2 Global Exosome Therapy Revenue by Company (2019-2024)
2.3 Key Companies Exosome Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Exosome Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Exosome Therapy
2.6 Exosome Therapy Market Competitive Analysis
2.6.1 Exosome Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Exosome Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Direct Treatment
3.1.2 Drug Delivery Vehicle
3.2 Global Exosome Therapy Sales Value by Type
3.2.1 Global Exosome Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Exosome Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Exosome Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Research Institutions
4.2 Global Exosome Therapy Sales Value by Application
4.2.1 Global Exosome Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Exosome Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Exosome Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Exosome Therapy Sales Value by Region
5.1.1 Global Exosome Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Exosome Therapy Sales Value by Region (2019-2024)
5.1.3 Global Exosome Therapy Sales Value by Region (2025-2030)
5.1.4 Global Exosome Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Exosome Therapy Sales Value, 2019-2030
5.2.2 North America Exosome Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Exosome Therapy Sales Value, 2019-2030
5.3.2 Europe Exosome Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Exosome Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Exosome Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Exosome Therapy Sales Value, 2019-2030
5.5.2 South America Exosome Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Exosome Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Exosome Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Exosome Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Exosome Therapy Sales Value
6.3 United States
6.3.1 United States Exosome Therapy Sales Value, 2019-2030
6.3.2 United States Exosome Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Exosome Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Exosome Therapy Sales Value, 2019-2030
6.4.2 Europe Exosome Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Exosome Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Exosome Therapy Sales Value, 2019-2030
6.5.2 China Exosome Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Exosome Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Exosome Therapy Sales Value, 2019-2030
6.6.2 Japan Exosome Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Exosome Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Exosome Therapy Sales Value, 2019-2030
6.7.2 South Korea Exosome Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Exosome Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Exosome Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Exosome Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Exosome Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Exosome Therapy Sales Value, 2019-2030
6.9.2 India Exosome Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Exosome Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 United Therapeutics Corporation
7.1.1 United Therapeutics Corporation Profile
7.1.2 United Therapeutics Corporation Main Business
7.1.3 United Therapeutics Corporation Exosome Therapy Products, Services and Solutions
7.1.4 United Therapeutics Corporation Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 United Therapeutics Corporation Recent Developments
7.2 Codiak BioSciences
7.2.1 Codiak BioSciences Profile
7.2.2 Codiak BioSciences Main Business
7.2.3 Codiak BioSciences Exosome Therapy Products, Services and Solutions
7.2.4 Codiak BioSciences Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Codiak BioSciences Recent Developments
7.3 EngEx™
7.3.1 EngEx™ Profile
7.3.2 EngEx™ Main Business
7.3.3 EngEx™ Exosome Therapy Products, Services and Solutions
7.3.4 EngEx™ Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Esperite Group Recent Developments
7.4 Esperite Group
7.4.1 Esperite Group Profile
7.4.2 Esperite Group Main Business
7.4.3 Esperite Group Exosome Therapy Products, Services and Solutions
7.4.4 Esperite Group Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Esperite Group Recent Developments
7.5 ArunA Biomedical
7.5.1 ArunA Biomedical Profile
7.5.2 ArunA Biomedical Main Business
7.5.3 ArunA Biomedical Exosome Therapy Products, Services and Solutions
7.5.4 ArunA Biomedical Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 ArunA Biomedical Recent Developments
7.6 Evox Therapeutics
7.6.1 Evox Therapeutics Profile
7.6.2 Evox Therapeutics Main Business
7.6.3 Evox Therapeutics Exosome Therapy Products, Services and Solutions
7.6.4 Evox Therapeutics Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Evox Therapeutics Recent Developments
7.7 NeurExo Sciences
7.7.1 NeurExo Sciences Profile
7.7.2 NeurExo Sciences Main Business
7.7.3 NeurExo Sciences Exosome Therapy Products, Services and Solutions
7.7.4 NeurExo Sciences Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 NeurExo Sciences Recent Developments
7.8 Tavec Pharmaceuticals
7.8.1 Tavec Pharmaceuticals Profile
7.8.2 Tavec Pharmaceuticals Main Business
7.8.3 Tavec Pharmaceuticals Exosome Therapy Products, Services and Solutions
7.8.4 Tavec Pharmaceuticals Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Tavec Pharmaceuticals Recent Developments
7.9 AEGLE Therapeutics
7.9.1 AEGLE Therapeutics Profile
7.9.2 AEGLE Therapeutics Main Business
7.9.3 AEGLE Therapeutics Exosome Therapy Products, Services and Solutions
7.9.4 AEGLE Therapeutics Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 AEGLE Therapeutics Recent Developments
7.10 Avalon GloboCare
7.10.1 Avalon GloboCare Profile
7.10.2 Avalon GloboCare Main Business
7.10.3 Avalon GloboCare Exosome Therapy Products, Services and Solutions
7.10.4 Avalon GloboCare Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 Avalon GloboCare Recent Developments
7.11 AlligatorBioscience
7.11.1 AlligatorBioscience Profile
7.11.2 AlligatorBioscience Main Business
7.11.3 AlligatorBioscience Exosome Therapy Products, Services and Solutions
7.11.4 AlligatorBioscience Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 AlligatorBioscience Recent Developments
7.12 Capricor Therapeutics
7.12.1 Capricor Therapeutics Profile
7.12.2 Capricor Therapeutics Main Business
7.12.3 Capricor Therapeutics Exosome Therapy Products, Services and Solutions
7.12.4 Capricor Therapeutics Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.12.5 Capricor Therapeutics Recent Developments
7.13 Stem Cell Medicine
7.13.1 Stem Cell Medicine Profile
7.13.2 Stem Cell Medicine Main Business
7.13.3 Stem Cell Medicine Exosome Therapy Products, Services and Solutions
7.13.4 Stem Cell Medicine Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.13.5 Stem Cell Medicine Recent Developments
7.14 CellTex Therapeutics
7.14.1 CellTex Therapeutics Profile
7.14.2 CellTex Therapeutics Main Business
7.14.3 CellTex Therapeutics Exosome Therapy Products, Services and Solutions
7.14.4 CellTex Therapeutics Exosome Therapy Revenue (US$ Million) & (2019-2024)
7.14.5 CellTex Therapeutics Recent Developments
8 Industry Chain Analysis
8.1 Exosome Therapy Industrial Chain
8.2 Exosome Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Exosome Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Exosome Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Exosome Therapy Market Trends
    Table 2. Exosome Therapy Market Drivers & Opportunity
    Table 3. Exosome Therapy Market Challenges
    Table 4. Exosome Therapy Market Restraints
    Table 5. Global Exosome Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Exosome Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Exosome Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Exosome Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Exosome Therapy
    Table 10. Global Exosome Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Exosome Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Exosome Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Exosome Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Exosome Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Exosome Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Exosome Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Exosome Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Exosome Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Exosome Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Exosome Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Exosome Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Exosome Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Exosome Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Exosome Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Exosome Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Exosome Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Exosome Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Exosome Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. United Therapeutics Corporation Basic Information List
    Table 32. United Therapeutics Corporation Description and Business Overview
    Table 33. United Therapeutics Corporation Exosome Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Exosome Therapy Business of United Therapeutics Corporation (2019-2024)
    Table 35. United Therapeutics Corporation Recent Developments
    Table 36. Codiak BioSciences Basic Information List
    Table 37. Codiak BioSciences Description and Business Overview
    Table 38. Codiak BioSciences Exosome Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Exosome Therapy Business of Codiak BioSciences (2019-2024)
    Table 40. Codiak BioSciences Recent Developments
    Table 41. EngEx™ Basic Information List
    Table 42. EngEx™ Description and Business Overview
    Table 43. EngEx™ Exosome Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Exosome Therapy Business of EngEx™ (2019-2024)
    Table 45. EngEx™ Recent Developments
    Table 46. Esperite Group Basic Information List
    Table 47. Esperite Group Description and Business Overview
    Table 48. Esperite Group Exosome Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Exosome Therapy Business of Esperite Group (2019-2024)
    Table 50. Esperite Group Recent Developments
    Table 51. ArunA Biomedical Basic Information List
    Table 52. ArunA Biomedical Description and Business Overview
    Table 53. ArunA Biomedical Exosome Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Exosome Therapy Business of ArunA Biomedical (2019-2024)
    Table 55. ArunA Biomedical Recent Developments
    Table 56. Evox Therapeutics Basic Information List
    Table 57. Evox Therapeutics Description and Business Overview
    Table 58. Evox Therapeutics Exosome Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Exosome Therapy Business of Evox Therapeutics (2019-2024)
    Table 60. Evox Therapeutics Recent Developments
    Table 61. NeurExo Sciences Basic Information List
    Table 62. NeurExo Sciences Description and Business Overview
    Table 63. NeurExo Sciences Exosome Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Exosome Therapy Business of NeurExo Sciences (2019-2024)
    Table 65. NeurExo Sciences Recent Developments
    Table 66. Tavec Pharmaceuticals Basic Information List
    Table 67. Tavec Pharmaceuticals Description and Business Overview
    Table 68. Tavec Pharmaceuticals Exosome Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Exosome Therapy Business of Tavec Pharmaceuticals (2019-2024)
    Table 70. Tavec Pharmaceuticals Recent Developments
    Table 71. AEGLE Therapeutics Basic Information List
    Table 72. AEGLE Therapeutics Description and Business Overview
    Table 73. AEGLE Therapeutics Exosome Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Exosome Therapy Business of AEGLE Therapeutics (2019-2024)
    Table 75. AEGLE Therapeutics Recent Developments
    Table 76. Avalon GloboCare Basic Information List
    Table 77. Avalon GloboCare Description and Business Overview
    Table 78. Avalon GloboCare Exosome Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Exosome Therapy Business of Avalon GloboCare (2019-2024)
    Table 80. Avalon GloboCare Recent Developments
    Table 81. AlligatorBioscience Basic Information List
    Table 82. AlligatorBioscience Description and Business Overview
    Table 83. AlligatorBioscience Exosome Therapy Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Exosome Therapy Business of AlligatorBioscience (2019-2024)
    Table 85. AlligatorBioscience Recent Developments
    Table 86. Capricor Therapeutics Basic Information List
    Table 87. Capricor Therapeutics Description and Business Overview
    Table 88. Capricor Therapeutics Exosome Therapy Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Exosome Therapy Business of Capricor Therapeutics (2019-2024)
    Table 90. Capricor Therapeutics Recent Developments
    Table 91. Stem Cell Medicine Basic Information List
    Table 92. Stem Cell Medicine Description and Business Overview
    Table 93. Stem Cell Medicine Exosome Therapy Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Exosome Therapy Business of Stem Cell Medicine (2019-2024)
    Table 95. Stem Cell Medicine Recent Developments
    Table 96. CellTex Therapeutics Basic Information List
    Table 97. CellTex Therapeutics Description and Business Overview
    Table 98. CellTex Therapeutics Exosome Therapy Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Exosome Therapy Business of CellTex Therapeutics (2019-2024)
    Table 100. CellTex Therapeutics Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Exosome Therapy Downstream Customers
    Table 104. Exosome Therapy Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Exosome Therapy Product Picture
    Figure 2. Global Exosome Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Exosome Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Exosome Therapy Report Years Considered
    Figure 5. Global Exosome Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Exosome Therapy Revenue in 2023
    Figure 7. Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Direct Treatment Picture
    Figure 9. Drug Delivery Vehicle Picture
    Figure 10. Global Exosome Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Exosome Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinic
    Figure 14. Product Picture of Research Institutions
    Figure 15. Global Exosome Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Exosome Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Exosome Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Exosome Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Exosome Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Exosome Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Exosome Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Exosome Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Exosome Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Exosome Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Exosome Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Exosome Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Exosome Therapy Sales Value (%), (2019-2030)
    Figure 28. United States Exosome Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Exosome Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Exosome Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Exosome Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Exosome Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Exosome Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Exosome Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Exosome Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Exosome Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Exosome Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Exosome Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Exosome Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Exosome Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Exosome Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Exosome Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Exosome Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Exosome Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Exosome Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Exosome Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Exosome Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Exosome Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 49. Exosome Therapy Industrial Chain
    Figure 50. Exosome Therapy Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS